-
1
-
-
77955635233
-
Cancer statistics, 2010
-
10.3322/caac.20073, 20610543
-
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
-
(2010)
CA Cancer J Clin
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
2
-
-
78049485263
-
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
-
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010,
-
(2010)
Int J Cancer
-
-
Ferlay, J.1
Shin, H.R.2
Bray, F.3
Forman, D.4
Mathers, C.5
Parkin, D.M.6
-
3
-
-
77953134174
-
Time trends of surgical outcome in patients with non-small cell lung cancer
-
10.1097/JTO.0b013e3181d5e47f, 20421823
-
Hanagiri T, Baba T, So T, Yasuda M, Sugaya M, Ono K, So T, Uramoto H, Takenoyama M, Yasumoto K. Time trends of surgical outcome in patients with non-small cell lung cancer. J Thorac Oncol 2010, 5:825-9. 10.1097/JTO.0b013e3181d5e47f, 20421823.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 825-829
-
-
Hanagiri, T.1
Baba, T.2
So, T.3
Yasuda, M.4
Sugaya, M.5
Ono, K.6
So, T.7
Uramoto, H.8
Takenoyama, M.9
Yasumoto, K.10
-
4
-
-
43249091308
-
Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry
-
10.1097/JTO.0b013e318164545d, 18317063
-
Ou SH, Zell JA. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry. J Thorac Oncol 2008, 3:216-27. 10.1097/JTO.0b013e318164545d, 18317063.
-
(2008)
J Thorac Oncol
, vol.3
, pp. 216-227
-
-
Ou, S.H.1
Zell, J.A.2
-
5
-
-
34548457234
-
International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
-
10.1097/JTO.0b013e31812f3c1a, 17762336
-
Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L. International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2:706-14. 10.1097/JTO.0b013e31812f3c1a, 17762336.
-
(2007)
J Thorac Oncol
, vol.2
, pp. 706-714
-
-
Goldstraw, P.1
Crowley, J.2
Chansky, K.3
Giroux, D.J.4
Groome, P.A.5
Rami-Porta, R.6
Postmus, P.E.7
Rusch, V.8
Sobin, L.9
-
6
-
-
0033993435
-
Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
-
10.1378/chest.117.2.358, 10669675
-
Sause W, Kolesar P, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran W, Byhardt R, Dar AR, Turrisi A. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000, 117:358-64. 10.1378/chest.117.2.358, 10669675.
-
(2000)
Chest
, vol.117
, pp. 358-364
-
-
Sause, W.1
Kolesar, P.2
Taylor, S.3
Johnson, D.4
Livingston, R.5
Komaki, R.6
Emami, B.7
Curran, W.8
Byhardt, R.9
Dar, A.R.10
Turrisi, A.11
-
7
-
-
43449127501
-
Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan
-
10.1007/s10147-007-0754-y, 18463953
-
Okamoto I. Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan. Int J Clin Oncol 2008, 13:112-6. 10.1007/s10147-007-0754-y, 18463953.
-
(2008)
Int J Clin Oncol
, vol.13
, pp. 112-116
-
-
Okamoto, I.1
-
8
-
-
19844364466
-
Multimodality therapy for stage III non-small-cell lung cancer
-
10.1200/JCO.2005.03.008, 15886313
-
Farray D, Mirkovic N, Albain KS. Multimodality therapy for stage III non-small-cell lung cancer. J Clin Oncol 2005, 23:3257-69. 10.1200/JCO.2005.03.008, 15886313.
-
(2005)
J Clin Oncol
, vol.23
, pp. 3257-3269
-
-
Farray, D.1
Mirkovic, N.2
Albain, K.S.3
-
9
-
-
68549098156
-
International Staging Committee and Participating Institutions. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer
-
10.1097/JTO.0b013e3181a7716e, 19458556
-
Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P. International Staging Committee and Participating Institutions. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 2009, 4:792-801. 10.1097/JTO.0b013e3181a7716e, 19458556.
-
(2009)
J Thorac Oncol
, vol.4
, pp. 792-801
-
-
Chansky, K.1
Sculier, J.P.2
Crowley, J.J.3
Giroux, D.4
Van Meerbeeck, J.5
Goldstraw, P.6
-
10
-
-
21644486386
-
The Japanese Joint Committee of Lung Cancer Registry. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study
-
10.1016/j.lungcan.2005.05.021, 16061304
-
Goya T, Asamura H, Yoshimura H, Kato H, Shimokata K, Tsuchiya R, Sohara Y, Miya T, Miyaoka E. The Japanese Joint Committee of Lung Cancer Registry. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 2005, 50:227-34. 10.1016/j.lungcan.2005.05.021, 16061304.
-
(2005)
Lung Cancer
, vol.50
, pp. 227-234
-
-
Goya, T.1
Asamura, H.2
Yoshimura, H.3
Kato, H.4
Shimokata, K.5
Tsuchiya, R.6
Sohara, Y.7
Miya, T.8
Miyaoka, E.9
-
11
-
-
0033890742
-
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications
-
Andre F, Grunenwald D, Pignon JP, Dujon A, Pujol JL, Brichon PY, Brouchet L, Quoix E, Westeel V, Le Chevalier T. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000, 18:2981-9.
-
(2000)
J Clin Oncol
, vol.18
, pp. 2981-2989
-
-
Andre, F.1
Grunenwald, D.2
Pignon, J.P.3
Dujon, A.4
Pujol, J.L.5
Brichon, P.Y.6
Brouchet, L.7
Quoix, E.8
Westeel, V.9
Le Chevalier, T.10
-
12
-
-
1842506221
-
Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe
-
10.1016/j.jtcvs.2003.09.012, 15052208
-
Inoue M, Sawabata N, Takeda S, Ohta M, Ohno Y, Maeda H. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg 2004, 127:1100-6. 10.1016/j.jtcvs.2003.09.012, 15052208.
-
(2004)
J Thorac Cardiovasc Surg
, vol.127
, pp. 1100-1106
-
-
Inoue, M.1
Sawabata, N.2
Takeda, S.3
Ohta, M.4
Ohno, Y.5
Maeda, H.6
-
13
-
-
0002487824
-
Histological type of lung and pleural tumors
-
Berlin: Springer, 3, eds
-
Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, . eds Histological type of lung and pleural tumors. World Health Organization international histological classification of tumors 1999, Berlin: Springer, 3, eds.
-
(1999)
World Health Organization international histological classification of tumors
-
-
Travis, W.D.1
Colby, T.V.2
Corrin, B.3
Shimosato, Y.4
Brambilla, E.5
-
14
-
-
34548462932
-
IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
-
10.1097/JTO.0b013e31812d05d5, 17762335
-
Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, Sobin LH, Goldstraw P. IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:694-705. 10.1097/JTO.0b013e31812d05d5, 17762335.
-
(2007)
J Thorac Oncol
, vol.2
, pp. 694-705
-
-
Groome, P.A.1
Bolejack, V.2
Crowley, J.J.3
Kennedy, C.4
Krasnik, M.5
Sobin, L.H.6
Goldstraw, P.7
-
15
-
-
33847276516
-
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
-
Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y, Fukuoka M. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol 2007, 18:317-23.
-
(2007)
Ann Oncol
, vol.18
, pp. 317-323
-
-
Ohe, Y.1
Ohashi, Y.2
Kubota, K.3
Tamura, T.4
Nakagawa, K.5
Negoro, S.6
Nishiwaki, Y.7
Saijo, N.8
Ariyoshi, Y.9
Fukuoka, M.10
-
16
-
-
35848945663
-
Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer
-
10.1097/JTO.0b013e318158d471, 17975493
-
Ilic N, Petricevic A, Arar D, Kotarac S, Banovic J, Ilic NF, Tripkovic A, Grandic L. Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer. J Thorac Oncol 2007, 2:1018-21. 10.1097/JTO.0b013e318158d471, 17975493.
-
(2007)
J Thorac Oncol
, vol.2
, pp. 1018-1021
-
-
Ilic, N.1
Petricevic, A.2
Arar, D.3
Kotarac, S.4
Banovic, J.5
Ilic, N.F.6
Tripkovic, A.7
Grandic, L.8
-
17
-
-
0037379852
-
Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer
-
10.1002/jso.10219, 12672010
-
Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Gutschow CA, Grass G, Schneider PM, Hölscher AH. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer. J Surg Oncol 2003, 82:256-60. 10.1002/jso.10219, 12672010.
-
(2003)
J Surg Oncol
, vol.82
, pp. 256-260
-
-
Prenzel, K.L.1
Mönig, S.P.2
Sinning, J.M.3
Baldus, S.E.4
Gutschow, C.A.5
Grass, G.6
Schneider, P.M.7
Hölscher, A.H.8
-
18
-
-
11144288761
-
Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis
-
10.1016/j.athoracsur.2004.06.081, 15620948
-
Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec Barthes F, Dujon A, Danel C. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg 2005, 79:225-33. 10.1016/j.athoracsur.2004.06.081, 15620948.
-
(2005)
Ann Thorac Surg
, vol.79
, pp. 225-233
-
-
Riquet, M.1
Assouad, J.2
Bagan, P.3
Foucault, C.4
Le Pimpec Barthes, F.5
Dujon, A.6
Danel, C.7
-
19
-
-
53849120572
-
The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer
-
10.1016/j.athoracsur.2008.07.076, 19049761
-
Misthos P, Sepsas E, Kokotsakis J, Skottis I, Lioulias A. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer. Ann Thorac Surg 2008, 86:1626-30. 10.1016/j.athoracsur.2008.07.076, 19049761.
-
(2008)
Ann Thorac Surg
, vol.86
, pp. 1626-1630
-
-
Misthos, P.1
Sepsas, E.2
Kokotsakis, J.3
Skottis, I.4
Lioulias, A.5
-
20
-
-
0028216204
-
A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
-
10.1093/jnci/86.9.673, 8158698
-
Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB, Lee JS, Dhingra H, De Caro L, Chasen M, McGavran M. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994, 86:673-80. 10.1093/jnci/86.9.673, 8158698.
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 673-680
-
-
Roth, J.A.1
Fossella, F.2
Komaki, R.3
Ryan, M.B.4
Putnam, J.B.5
Lee, J.S.6
Dhingra, H.7
De Caro, L.8
Chasen, M.9
McGavran, M.10
-
21
-
-
0037797249
-
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA PN2 non-small-cell lung cancer: a multicenter phase II trial
-
10.1200/JCO.2003.11.040, 12721251
-
Betticher DC, Hsu Schmitz SF, Tötsch M, Hansen E, Joss C, von Briel C, Schmid RA, Pless M, Habicht J, Roth AD, Spiliopoulos A, Stahel R, Weder W, Stupp R, Egli F, Furrer M, Honegger H, Wernli M, Cerny T, Ris HB. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA PN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 2003, 21:1752-1759. 10.1200/JCO.2003.11.040, 12721251.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1752-1759
-
-
Betticher, D.C.1
Hsu Schmitz, S.F.2
Tötsch, M.3
Hansen, E.4
Joss, C.5
von Briel, C.6
Schmid, R.A.7
Pless, M.8
Habicht, J.9
Roth, A.D.10
Spiliopoulos, A.11
Stahel, R.12
Weder, W.13
Stupp, R.14
Egli, F.15
Furrer, M.16
Honegger, H.17
Wernli, M.18
Cerny, T.19
Ris, H.B.20
more..
-
22
-
-
9444287122
-
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience
-
10.1093/annonc/mdh435, 15520066, Leuven Lung Cancer Group
-
Lorent N, De Leyn P, Lievens Y, Verbeken E, Nackaerts K, Dooms C, Van Raemdonck D, Anrys B, Vansteenkiste J, . Leuven Lung Cancer Group Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience. Ann Oncol 2004, 15:1645-1653. 10.1093/annonc/mdh435, 15520066, Leuven Lung Cancer Group.
-
(2004)
Ann Oncol
, vol.15
, pp. 1645-1653
-
-
Lorent, N.1
De Leyn, P.2
Lievens, Y.3
Verbeken, E.4
Nackaerts, K.5
Dooms, C.6
Van Raemdonck, D.7
Anrys, B.8
Vansteenkiste, J.9
-
23
-
-
53649097712
-
Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement
-
10.1016/j.thorsurg.2008.07.004, 19086609
-
Tieu BH, Sanborn RE, Thomas CR. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement. Thorac Surg Clin 2008, 18:403-15. 10.1016/j.thorsurg.2008.07.004, 19086609.
-
(2008)
Thorac Surg Clin
, vol.18
, pp. 403-415
-
-
Tieu, B.H.1
Sanborn, R.E.2
Thomas, C.R.3
-
24
-
-
67651241508
-
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
-
10.1016/S0140-6736(09)60737-6, 19632716
-
Albain KS, Swann RS, Rusch VW, Turrisi AT, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara DR, Fry WA, Darling G, Johnson DH, Green MR, Miller RC, Ley J, Sause WT, Cox JD. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009, 374:379-86. 10.1016/S0140-6736(09)60737-6, 19632716.
-
(2009)
Lancet
, vol.374
, pp. 379-386
-
-
Albain, K.S.1
Swann, R.S.2
Rusch, V.W.3
Turrisi, A.T.4
Shepherd, F.A.5
Smith, C.6
Chen, Y.7
Livingston, R.B.8
Feins, R.H.9
Gandara, D.R.10
Fry, W.A.11
Darling, G.12
Johnson, D.H.13
Green, M.R.14
Miller, R.C.15
Ley, J.16
Sause, W.T.17
Cox, J.D.18
-
25
-
-
68749106139
-
Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival
-
10.1016/j.ejcts.2009.04.013, 19502079
-
Decaluwé H, De Leyn P, Vansteenkiste J, Dooms C, Van Raemdonck D, Nafteux P, Coosemans W, Lerut T. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival. Eur J Cardiothorac Surg 2009, 36:433-9. 10.1016/j.ejcts.2009.04.013, 19502079.
-
(2009)
Eur J Cardiothorac Surg
, vol.36
, pp. 433-439
-
-
Decaluwé, H.1
De Leyn, P.2
Vansteenkiste, J.3
Dooms, C.4
Van Raemdonck, D.5
Nafteux, P.6
Coosemans, W.7
Lerut, T.8
-
26
-
-
67651146522
-
Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial
-
10.1016/S1470-2045(09)70172-X, 19604722
-
Stupp R, Mayer M, Kann R, Weder W, Zouhair A, Betticher DC, Roth AD, Stahel RA, Majno SB, Peters S, Jost L, Furrer M, Thierstein S, Schmid RA, Hsu-Schmitz SF, Mirimanoff RO, Ris HB, Pless M. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. Lancet Oncol 2009, 10:785-93. 10.1016/S1470-2045(09)70172-X, 19604722.
-
(2009)
Lancet Oncol
, vol.10
, pp. 785-793
-
-
Stupp, R.1
Mayer, M.2
Kann, R.3
Weder, W.4
Zouhair, A.5
Betticher, D.C.6
Roth, A.D.7
Stahel, R.A.8
Majno, S.B.9
Peters, S.10
Jost, L.11
Furrer, M.12
Thierstein, S.13
Schmid, R.A.14
Hsu-Schmitz, S.F.15
Mirimanoff, R.O.16
Ris, H.B.17
Pless, M.18
-
27
-
-
0346238665
-
International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
-
Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J. International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004, 350:351-60.
-
(2004)
N Engl J Med
, vol.350
, pp. 351-360
-
-
Arriagada, R.1
Bergman, B.2
Dunant, A.3
Le Chevalier, T.4
Pignon, J.P.5
Vansteenkiste, J.6
-
28
-
-
33747847740
-
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
-
10.1016/S1470-2045(06)70804-X, 16945766
-
Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonzáles-Larriba JL, Grodzki T, Pereira JR, Le Groumellec A, Lorusso V, Clary C, Torres AJ, Dahabreh J, Souquet PJ, Astudillo J, Fournel P, Artal-Cortes A, Jassem J, Koubkova L, His P, Riggi M, Hurteloup P. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006, 7:719-27. 10.1016/S1470-2045(06)70804-X, 16945766.
-
(2006)
Lancet Oncol
, vol.7
, pp. 719-727
-
-
Douillard, J.Y.1
Rosell, R.2
De Lena, M.3
Carpagnano, F.4
Ramlau, R.5
Gonzáles-Larriba, J.L.6
Grodzki, T.7
Pereira, J.R.8
Le Groumellec, A.9
Lorusso, V.10
Clary, C.11
Torres, A.J.12
Dahabreh, J.13
Souquet, P.J.14
Astudillo, J.15
Fournel, P.16
Artal-Cortes, A.17
Jassem, J.18
Koubkova, L.19
His, P.20
Riggi, M.21
Hurteloup, P.22
more..
-
29
-
-
49049109683
-
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
-
10.1200/JCO.2007.13.9030, 18506026, LACE Collaborative Group
-
Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Le Chevalier T, . LACE Collaborative Group Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008, 26:3552-9. 10.1200/JCO.2007.13.9030, 18506026, LACE Collaborative Group.
-
(2008)
J Clin Oncol
, vol.26
, pp. 3552-3559
-
-
Pignon, J.P.1
Tribodet, H.2
Scagliotti, G.V.3
Douillard, J.Y.4
Shepherd, F.A.5
Stephens, R.J.6
Dunant, A.7
Torri, V.8
Rosell, R.9
Seymour, L.10
Spiro, S.G.11
Rolland, E.12
Fossati, R.13
Aubert, D.14
Ding, K.15
Waller, D.16
Le Chevalier, T.17
-
30
-
-
34548145056
-
Postoperative radiotherapy for non-small cell lung cancer
-
PORT Meta-analysis Trialists Group
-
PORT Meta-analysis Trialists Group Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2005, 18:CD002142. PORT Meta-analysis Trialists Group.
-
(2005)
Cochrane Database Syst Rev
, vol.18
-
-
-
31
-
-
70249139904
-
Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer
-
10.1007/s11864-009-0090-8, 19387842
-
Krupitskaya Y, Loo BW. Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer. Curr Treat Options Oncol 2008, 9:343-56. 10.1007/s11864-009-0090-8, 19387842.
-
(2008)
Curr Treat Options Oncol
, vol.9
, pp. 343-356
-
-
Krupitskaya, Y.1
Loo, B.W.2
|